FDx Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,065
| Closed | -$4.69M | – | 338 |
|
|
2024
Q1 | $4.69M | Buy |
8,065
+355
| +5% | +$199K | 0.71% | 39 |
|
|
2023
Q4 | $4.09M | Buy |
7,710
+1,818
| +31% | +$880K | 0.32% | 82 |
|
|
2023
Q3 | $2.98M | Sell |
5,892
-6,511
| -52% | -$3.47M | 0.25% | 101 |
|
|
2023
Q2 | $6.47M | Sell |
12,403
-32,858
| -73% | -$17.7M | 0.35% | 74 |
|
|
2023
Q1 | $24.9M | Hold |
45,261
| – | – | 1.08% | 16 |
|
|
2022
Q4 | $24.9M | Buy |
45,261
+43,248
| +2,148% | +$22.9M | 1.08% | 16 |
|
|
2022
Q3 | $1.02M | Sell |
2,013
-520
| -21% | -$291K | 0.05% | 279 |
|
|
2022
Q2 | $1.38M | Sell |
2,533
-27
| -1% | -$14.9K | 0.05% | 261 |
|
|
2022
Q1 | $1.51M | Buy |
2,560
+97
| +4% | +$55.7K | 0.05% | 253 |
|
|
2021
Q4 | $1.64M | Buy |
2,463
+553
| +29% | +$345K | 0.05% | 261 |
|
|
2021
Q3 | $1.09M | Buy |
1,910
+197
| +12% | +$108K | 0.03% | 319 |
|
|
2021
Q2 | $864K | Sell |
1,713
-80
| -4% | -$37.7K | 0.03% | 362 |
|
|
2021
Q1 | $818K | Sell |
1,793
-1,257
| -41% | -$600K | 0.03% | 347 |
|
|
2020
Q4 | $1.42M | Sell |
3,050
-2,816
| -48% | -$1.32M | 0.06% | 210 |
|
|
2020
Q3 | $2.59M | Sell |
5,866
-1,001
| -15% | -$414K | 0.12% | 134 |
|
|
2020
Q2 | $2.49M | Buy |
6,867
+626
| +10% | +$210K | 0.13% | 125 |
|
|
2020
Q1 | $1.77M | Buy |
6,241
+193
| +3% | +$60.9K | 0.12% | 135 |
|
|
2019
Q4 | $1.97M | Sell |
6,048
-222
| -4% | -$67.3K | 0.11% | 152 |
|
|
2019
Q3 | $1.83M | Sell |
6,270
-3,575
| -36% | -$1.02M | 0.13% | 143 |
|
|
2019
Q2 | $2.89M | Buy |
9,845
+3,410
| +53% | +$939K | 0.11% | 150 |
|
|
2019
Q1 | $1.76M | Buy |
6,435
+2,681
| +71% | +$667K | 0.07% | 197 |
|
|
2018
Q4 | $840K | Sell |
3,754
-2,335
| -38% | -$548K | 0.07% | 207 |
|
|
2018
Q3 | $1.49M | Buy |
6,089
+1,401
| +30% | +$322K | 0.06% | 263 |
|
|
2018
Q2 | $971K | Sell |
4,688
-9,342
| -67% | -$1.98M | 0.04% | 372 |
|
|
2018
Q1 | $2.9M | Hold |
14,030
| – | – | 0.09% | 203 |
|
|
2017
Q4 | $2.66M | Sell |
14,030
-1,078
| -7% | -$207K | 0.07% | 232 |
|
|
2017
Q3 | $2.86M | Sell |
15,108
-2,031
| -12% | -$368K | 0.08% | 219 |
|
|
2017
Q2 | $2.99M | Buy |
17,139
+638
| +4% | +$107K | 0.09% | 189 |
|
|
2017
Q1 | $2.54M | Buy |
16,501
+7,023
| +74% | +$1.07M | 0.08% | 238 |
|
|
2016
Q4 | $1.34M | Buy |
9,478
+2,436
| +35% | +$359K | 0.04% | 431 |
|
|
2016
Q3 | $1.12M | Sell |
7,042
-143
| -2% | -$22K | 0.05% | 361 |
|
|
2016
Q2 | $1.06M | Sell |
7,185
-927
| -11% | -$137K | 0.05% | 341 |
|
|
2016
Q1 | $1.15M | Buy |
8,112
+161
| +2% | +$21.6K | 0.05% | 318 |
|
|
2015
Q4 | $1.13M | Buy |
7,951
+3,298
| +71% | +$440K | 0.05% | 315 |
|
|
2015
Q3 | $569K | Buy |
4,653
+2,619
| +129% | +$341K | 0.05% | 408 |
|
|
2015
Q2 | $264K | Sell |
2,034
-2,966
| -59% | -$387K | 0.01% | 797 |
|
|
2015
Q1 | $673K | Buy |
5,000
+686
| +16% | +$88.4K | 0.01% | 784 |
|
|
2014
Q4 | $541K | Sell |
4,314
-213
| -5% | -$25.9K | 0.03% | 527 |
|
|
2014
Q3 | $551K | Buy |
4,527
+230
| +5% | +$28K | 0.04% | 542 |
|
|
2014
Q2 | $507K | Buy |
4,297
+492
| +13% | +$57.9K | 0.03% | 578 |
|
|
2014
Q1 | $458K | Buy |
3,805
+897
| +31% | +$107K | 0.04% | 461 |
|
|
2013
Q4 | $324K | Sell |
2,908
-617
| -18% | -$61.4K | 0.03% | 499 |
|
|
2013
Q3 | $325K | Sell |
3,525
-545
| -13% | -$49.3K | 0.04% | 404 |
|
|
2013
Q2 | $344K | Buy |
+4,070
| New | +$339K | 0.05% | 347 |
|
Other funds holding TMO
FDx Advisors's TMO Position: Q2 2024 in Review
FDx Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 8,065 shares — an estimated $4.69M sold.
FDx Advisors first reported a position in TMO in Q2 2013 and held it in 44 quarters. The position peaked at $24.9M in Q1 2023. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- FDx Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
- FDx Advisors sold 8,065 Thermo Fisher Scientific shares in Q2 2024, an estimated $4.69M.
- FDx Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 44 quarters.
- FDx Advisors's Thermo Fisher Scientific position peaked at $24.9M in Q1 2023.
- 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on FDx Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.